Design and Mechanism of On–Off Pulsed Drug Release Using Nonenteric Polymeric Systems via pH Modulation
Tóm tắt
The aim was to design a pH-sensitive pulsatile drug delivery system that allows for an on–off pulsed release of a drug using polyacrylic acid (PAA) blended with ethyl cellulose (EC) in different ratios. PAA, a polyelectrolyte polymer, exhibits a highly coiled conformation at low pH but a highly extended structure at high pH. Fumaric acid, which is an internal acidifying agent, was incorporated into the hydroxypropyl methylcellulose-based core tablets to create an acidic microenvironmental pH (pHM). The concentration of fumaric acid inside the core tablet and the ratio of PAA/EC in the coating layer were very crucial in modulating drug release behaviors. When the fumaric acid was retained in the core tablet, it gave a more acidic pHM, so that the PAA was kept in a highly coiled state in the coated film, which hindered drug release (“off” release pattern). Interestingly, the release profiles of the drug and fumaric acid from coated tablets showed the on–off pulsed pattern upon dissolution. Imaging analyses using scanning electron microscopy, near-infrared imaging, confocal laser scanning microscopy, and Fourier transform infrared spectroscopy confirmed this on–off release behavior of the drug and fumaric acid from coated tablets.
Tài liệu tham khảo
Stubbe BG, Smedt SCD, Demeester J. “Programmed polymeric devices” for pulsed drug delivery. Pharm Res. 2004;21:1732–40.
Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: an approach for controlled drug delivery. Indian J Pharm Sci. 2006;68:295–300.
Anal AK. Time-controlled pulsatile delivery systems for bioactive compounds. Recent Pat Drug Deliv Formul. 2007;1:73–9.
Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Contr Rel. 2009;134:74–80.
Wallaert B, Brun P, Ostinelli J, Murciano D, Champel F, Blaive B, et al. The French bambuterol study group. A comparison of two long acting β-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. Respir Med. 1999;93:33–8.
D’alonzo GE, Smolensky MH, Feldman S, Gnosspelius Y, Karlsson K. Bambuterol in the treatment of asthma: a placebo-controlled comparison of once-daily morning vs. evening administration. Chest. 1995;107:406–12.
Nyberg L, Rosenborg J, Weibull E, Jönsson S, Kennedy BM, Nilsson M. Pharmacokinetics of bambuterol in healthy subjects. Br J Clin Phamacol. 1998;45:471–8.
Rosenborg J, Larsson P, Nyberg L. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults. Br J Clin Phamacol. 2000;49:199–206.
Lee B-J, Min G-H. Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. Int J Pharm. 1996;144:37–46.
Cao Q-R, Choi H-G, Kim D-C, Lee B-J. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions. Int J Pharm. 2004;274:107–17.
Ozturk AG, Ozturk SS, Palsson BO, Wheatley TA, Dressman JB. Mechanism of release from pellets coated with an ethylcellulose-based film. J Contr Rel. 1990;14:203–13.
Borgquist P, Zackrisson G, Nilsson B, Axelsson A. Simulation and parametric study of a film-coated controlled-release pharmaceutical. J Contr Rel. 2002;80:229–45.
Muschert S, Siepmann F, Leclercq B, Carlin B, Siepmann J. Prediction of drug release from ethylcellulose coated pellets. J Contr Rel. 2009;135:71–9.
Siepmann F, Hoffmann A, Leclercq B, Carlin B, Siepmann J. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Contr Rel. 2007;119:182–9.
Sakellariou P, Rowe RC, White EFT. Polymer/polymer interaction in blends of ethyl cellulose with both cellulose derivatives and polyethylene glycol 6000. Int J Pharm. 1986;34:93–103.
Sakellariou P, Rowe RC. The morphology of blends of ethylcellulose with hydroxypropyl methylcellulose as used in film coating. Int J Pharm. 1995;125:289–96.
Wong D, Bodmeier R. Flocculation of an aqueous colloidal ethyl cellulose dispersion (Aquacoat) with a water-soluble polymer, hydroxypropyl methylcellulose. Eur J Pharm Biopharm. 1996;42:12–5.
Suh J, Paik H-J, Hwang BK. Ionization of poly(ethylenimine) and poly(allylamine) at various pH’s. Bioorg Chem. 1994;22:318–27.
Grunlan JC, Liu L, Regev O. Weak polyelectrolyte control of carbon nanotube dispersion in water. J Collo Int Sci. 2008;317:346–9.
Tran PHL, Tran HTT, Lee B-J. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Contr Rel. 2008;129:59–65.
Tran TT-D, Tran PH-L, Lee B-J. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug. Eur J Pharm Biopharm. 2009;72:83–90.
Piao Z-Z, Lee M-K, Lee B-J. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex. Int J Pharm. 2008;350:205–11.
British Pharmacopoeia Commission. British Pharmacopoeia 2001 (BP 2001). London: Stationery Office; 2001.
Tran TT-D, Tran PH-L, Choi H-G, Han H-K, Lee B-J. The roles of acidifiers in solid dispersions and physical mixtures. Int J Pharm. 2010;384:60–6.
Siepmann J, Kranz H, Bodmeier R, Peppas NA. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res. 1999;16:1748–56.
Miranda A, Millán M, Caraballo I. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int J Pharm. 2006;311:75–81.
Nair A, Gupta R, Vasanti S. In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product. Pharm Dev Tech. 2007;12:621–5.
Lee B-J, Ryu S-G, Cui J-H. Formulation and release characteristics of hydroxypropylmethylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm. 1999;25:493–501.
Lee B-J, Ryu S-G, Cui J-H. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings. Int J Pharm. 1999;188:71–80.
Baveja SK, Rao KVR, Devi KP. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int J Pharm. 1987;39:39–45.
Devi KP, Rao KVR, Baveja S, Fathi M, Roth M. Zero-order release formulation of oxprenolol hydrochloride with swelling and erosion control. Pharm Res. 1989;6:313–7.
Danckwerts MP. Development of a zero-order release oral compressed tablet with potential for commercial tabletting production. Int J Pharm. 1994;112:37–45.
Thoma K, Zimmer T. Retardation of weakly basic drugs with diffusion tablets. Int J Pharm. 1990;58:197–202.
Gabr KE. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur J Pharm Biopharm. 1992;38:199–202.
Streubel A, Siepmann J, Dashevsky A, Bodmeier R. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J Contr Rel. 2000;67:101–10.
Kranz H, Brun VL, Wagner T. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug. Int J Pharm. 2005;299:84–91.
Kranz H, Guthmannb C, Wagner T, Lipp R, Reinhard J. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Eur J Pharm Sci. 2005;26:47–53.
Siepe S, Lueckel B, Krammer A, Ries A, Gurny R. Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int J Pharm. 2006;316:14–20.
Espinoza R, Hong E, Villafuerte L. Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. Int J Pharm. 2000;201:165–73.
Varma MVS, Kaushal AM, Garg S. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. J Contr Rel. 2005;103:499–510.
Tatavarti AS, Hoag SW. Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J Pharm Sci. 2006;95:1459–68.
Siepe S, Herrmann W, Borchert HH, Lueckel B, Kramer A, Ries A, et al. Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study. J Contr Rel. 2006;112:72–8.
Siepe S, Lueckel B, Kramer A, Ries A, Gurny R. Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound. Drug Dev Ind Pharm. 2008;34:46–52.
Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydro-philic and hydrophobic matrix system. AAPS Pharm Sci Tech. 2003;4:1–6.
Piao Z-Z, Lee K-H, Kim D-J, Lee B-J. Comparison of release-controlling efficiency of polymeric coating materials using matrix-type casted films and diffusion-controlled coated tablet. AAPS Pharm Sci Tech. 2010;11(2):630–6. doi:10.1208/s12249-010-9377-0.
Hammer M, Schweitzer D, Richter S, Königsdörffer E. Sodium fluorescein as a retinal pH indicator? Physiol Meas. 2005;26:N9–12.
Reich G. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv Drug Deliv Rev. 2005;57:1109–43.
Awa K, Okumura T, Shinzawa H, Otsukac M, Ozaki Y. Self-modeling curve resolution (SMCR) analysis of near-infrared (NIR) imaging data of pharmaceutical tablets. Anal Chim Acta. 2008;619:81–6.
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60.
Choi J, Rubner MF. Influence of the degree of ionization on weak polyelectrolyte multilayer assembly. Macromolecules. 2005;38:116–24.